![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
BM Sharp and HS Beyer
The dose of nicotine and the frequency of its administration appear to be essential determinants of its action on multiple systems including the neuroendocrine regulation of the adrenocorticotropin (ACTH)- corticosterone and prolactin (PRL) axes in the rat. Because desensitization to the acute depressive effects of nicotine has been observed after both acute and chronic administration, these investigations assessed whether desensitization to the stimulative effects of nicotine on ACTH and PRL secretion occurs with repetitive dosing. Extensive dose and time course experiments showed that nicotine rapidly elevates rat plasma ACTH and PRL levels with a threshold dose between 0.1 to 0.25 mg/kg b.wt. i.p. After the stimulation of PRL, levels became significantly depressed. Desensitization to the acute stimulatory effects of nicotine on both hormones was induced by a single dose of nicotine (0.5 mg/kg). One hour later nicotine (1.0 mg/kg) failed to significantly stimulate PRL levels and resulted in a modest increase of ACTH. Desensitization was maximal by 1 hr after the first dose and persisted for at least 6 hr. Adrenalectomy, performed to eliminate corticosterone-induced negative feedback, did not enhance PRL responsiveness to a second dose of nicotine but it partially restored the ACTH response. Pretreatment with corticosterone also failed to modify the PRL response to a single dose of nicotine whereas it partially suppressed the ACTH response. Rapid desensitization to the acute stimulatory effects of nicotine on plasma PRL is independent of glucocorticoid negative-feedback whereas desensitization of the ACTH response is modestly dependent.
This article has been cited by other articles:
|
|
 |
|
  Y. Xiao, H. Fan, J. L. Musachio, Z.-L. Wei, S. K. Chellappan, A. P. Kozikowski, and K. J. Kellar Sazetidine-A, A Novel Ligand That Desensitizes {alpha}4beta2 Nicotinic Acetylcholine Receptors without Activating Them Mol. Pharmacol., October 1, 2006; 70(4): 1454 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Rasmusson, M. R. Picciotto, and S. Krishnan-Sarin Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review J Psychopharmacol, September 1, 2006; 20(5): 693 - 707. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Y. Lopez-Hernandez, J. Sanchez-Padilla, A. Ortiz-Acevedo, J. Lizardi-Ortiz, J. Salas-Vincenty, L. V. Rojas, and J. A. Lasalde-Dominicci Nicotine-induced Up-regulation and Desensitization of {alpha}4{beta}2 Neuronal Nicotinic Receptors Depend on Subunit Ratio J. Biol. Chem., September 3, 2004; 279(36): 38007 - 38015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Mendelson, M. B. Sholar, N. H. Mutschler, M. Jaszyna-Gasior, N. V. Goletiani, A. J. Siegel, and N. K. Mello Effects of Intravenous Cocaine and Cigarette Smoking on Luteinizing Hormone, Testosterone, and Prolactin in Men J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 339 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Sarnyai, Y. Shaham, and S. C. Heinrichs The Role of Corticotropin-Releasing Factor in Drug Addiction Pharmacol. Rev., June 1, 2001; 53(2): 209 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Perry, M. I. Dávila-García, C. A. Stockmeier, and K. J. Kellar Increased Nicotinic Receptors in Brains from Smokers: Membrane Binding and Autoradiography Studies J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1545 - 1552. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Fu, S. G. Matta, and B. M. Sharp Local alpha -Bungarotoxin-Sensitive Nicotinic Receptors Modulate Hippocampal Norepinephrine Release by Systemic Nicotine J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 133 - 139. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Fu, S. G. Matta, T. J. James, and B. M. Sharp Nicotine-Induced Norepinephrine Release in the Rat Amygdala and Hippocampus is Mediated through Brainstem Nicotinic Cholinergic Receptors J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1188 - 1196. [Abstract] [Full Text]
|
|
|
|
|
|
F. Olale, V. Gerzanich, A. Kuryatov, F. Wang, and J. Lindstrom Chronic Nicotine Exposure Differentially Affects the Function of Human alpha 3, alpha 4, and alpha 7 Neuronal Nicotinic Receptor Subtypes J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 675 - 683. [Abstract] [Full Text]
|
|
|
|
|
|
K. Fattinger, D. Verotta, and N. L. Benowitz J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1238 - 1246. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Fu, S. G. Matta, J. D. Valentine, and B. M. Sharp Adrenocorticotropin Response and Nicotine-Induced Norepinephrine Secretion in the Rat Paraventricular Nucleus Are Mediated through Brainstem Receptors Endocrinology, May 1, 1997; 138(5): 1935 - 1943. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
